Key result
Type 2 diabetes does not impact mortality after open repair of acute type A aortic dissection.
Why the study?
Previous studies reported a protective effect of type 2 diabetes on aortic aneurysms, prompting investigation into whether this protective effect extends to aortic dissections.
Does diabetes increase in-hospital or short-term mortality in patients undergoing surgical repair for type A aortic dissection?
Cohort (n=7,324)
Yes
Does diabetes increase in-hospital or short-term mortality in patients undergoing surgical repair for type A aortic dissection?
Answers are grounded in this paper and cite their sources.
Diabetes does not increase the risk of in-hospital or 30-day mortality following open surgical repair for acute type A aortic dissection, though it is associated with a higher risk of acute renal failure.
BACKGROUND: Previous studies have reported a protective effect of type 2 diabetes on the incidence and progression of aortic aneurysms. We investigated whether this protective effect extends to aortic dissections. METHODS: Data from the US Nationwide Readmission Database (2016-2019) were analyzed. Patients admitted for open surgery repair of acute type A aortic dissection (TAAD) were initially analyzed (index group). Those discharged alive were followed for up to 30 days (readmission group). The co-primary outcomes were in-hospital and 30-day mortality. RESULTS: Between 2016 and 2019, 7,324 patients were admitted for open surgical repair of acute TAAD, of whom 965 (13.2%) had diabetes. Patients with diabetes were older and had a higher prevalence of obesity, hypertension, smoking, dyslipidemia, and chronic kidney disease (CKD). 15.2% of patients with diabetes and 14.6% without diabetes died; hence, diabetes did not have a significant impact on in-hospital mortality (adjusted odd ratio [aOR] = 1.02 [0.84-1.24]). Similarly, diabetes was not associated with a higher adjusted risk of atrial fibrillation (aOR = 1.03 [0.89-1.20]), stroke (aOR = 0.83 [0.55-1.26]), cardiogenic shock (aOR = 1.18 [0.98-1.42]), but increased the risk of acute renal failure (aOR = 1.20 [1.04-1.39]). Within 30 days of discharge, 154 (15.9%) patients with diabetes and 952 (15%) from the non-diabetes group were readmitted. Readmitted patients with diabetes were older and had a higher prevalence of cardiovascular comorbidities. We didn't observe any significant difference in the adjusted risk of 30-day mortality between the diabetes and non-diabetes groups (adjusted hazard ratio [aHR] = 0.81 [0.41-1.60]). However, diabetes was associated with a lower risk of readmission (aHR = 0.81 [0.68-0.97]). Age was the most significant predictor of all outcomes. CKD was the most significant predictor of 30-day mortality, with the risk increasing five-fold in patients with diabetes (HR = 5.58 [2.58-6.62]. Cardiovascular-related conditions were the most common causes of readmission in both groups. However, respiratory-related conditions were more prevalent in the diabetes group compared to the non-diabetes group (19.5% vs. 13%, respectively, p = 0.032). CONCLUSIONS: Diabetes does not increase in-hospital or short-term mortality in patients undergoing surgical repair for Type A aortic dissection.
No takes yet. Share an insight, caveat, or question.
Chaudhry et al. (2024) conducted a cohort in Acute type A aortic dissection (TAAD) (n=7,324). Type 2 diabetes vs. Non-diabetes was evaluated on In-hospital mortality (aOR 1.02, 95% CI 0.84-1.24, p=0.847). Type 2 diabetes did not significantly impact in-hospital mortality (aOR 1.02) or 30-day mortality (aHR 0.81) in patients undergoing open surgical repair for acute type A aortic dissection.
Synapse has enriched 10 related papers. Consider them for comparative context: